A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular Risk

Completed

Plain-English translation of NCT03730662 on ClinicalTrials.gov ↗ · Source last updated February 2022 · How we translate trials

Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.

Trial locations(216 sites)

United States

Advanced Research Center, Anaheim, California

Valley Clinical Trials, Inc., Covina, California

Marin Endocrine Associates, Greenbrae, California

National Research Institute, Huntington Park, California

Scripps Whittier Diabetes Institute, La Jolla, California